Freunds adjuvant alone is antiatherogenic in apoE-deficient mice and specific immunization against TNFα confers no additional benefit
- 30 September 2001
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 158 (1) , 87-94
- https://doi.org/10.1016/s0021-9150(01)00418-x
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- The Role of Tumor Necrosis Factor-α Receptors in AtherosclerosisTrends in Cardiovascular Medicine, 1998
- A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's DiseaseNew England Journal of Medicine, 1997
- Cell-mediated immunity in atherosclerosisCurrent Opinion in Lipidology, 1997
- Is atherosclerosis an immunologically mediated disease?Immunology Today, 1995
- Cytokines Regulate Vascular Functions Related to Stability of the Atherosclerotic PlaqueJournal of Cardiovascular Pharmacology, 1995
- Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritisThe Lancet, 1994
- In vivo blockade of tumor necrosis factor-alpha in cholesterol-fed rabbits after cardiac transplant inhibits acute coronary artery neointimal formation.Circulation, 1994
- The molecular action of tumor necrosis factor‐αEuropean Journal of Biochemistry, 1991
- The Biology of Cachectin/TNF -- A Primary Mediator of the Host ResponseAnnual Review of Immunology, 1989